5 Penny Stocks Under $1 On Popular Brokers This Week
All of the excitement in penny stocks this year has traders looking for places to call home. The issues faced by Robinhood users recently, thanks to a massive spike in certain stocks, have some traders searching for a new broker.
However, Fidelity, TD Ameritrade, Etrade, Interactive Brokers, and others are different. They not only allow trading of Nasdaq and NYSE listed stocks, but they also allow users to buy penny stocks trading on the OTC. This opens up an entirely new set of companies that were once inaccessible.
Penny Stocks Under $1 To Buy [or avoid]
Penny Stocks To Buy [or avoid] #1: Kelso Technologies Inc
Kelso Tech may be a new penny stock on your list. Only recently has KIQ begun seeing stronger trading momentum. Needless to say, even with that as the case, shares are up more than 60% this year already. The company specializes in components for railway and roadway transportation. In fact, the company just raised $CAD 6.3 million to put toward its marketing and new product development last week.
James R. Bond, CEO of the Company weighed in on the latest milestone.
“This Private Placement is the first time since September 2012 that Kelso has sought to access new equity capital from the investment community to help finance the Company's ongoing R&D and business development plans. The Company has generated over US$120 million dollars in revenue at above-average profit margins over the past decade.”
#2. Gran Tierra Energy Inc.
[Read More] 5 Penny Stocks To Watch As Tesla Boosts Bitcoin Prices
#3: Onconova Therapeutics Inc.
As of the time of this article, Onconova shares just peeked above the $1 mark. The company has been on our watch lists for months at this point, with a core focus on Onconova’s pipeline development. Back in December, we discussed the company as insiders were buying up shares. This was when the company had also filed for an Investigational New Drug application for its ON 123300 cancer treatment.
Why timing could be a factor has a lot to do with what Onconova set as an expectation for the treatment. In particular, the IND seeks to gain permission to start Phase 1 trials in the U.S. in patients with breast cancer, and the company expects that to start in the first half of this year. There is an ongoing Phase 1 trial in China with ON 123300, and it continues to enroll patients.
#4. Acasti Pharma Inc.
Another one of the biotech penny stocks on our list for a while is Acasti. The company focuses on its CaPre hypertriglyceridemia treatment. There haven’t been many positive developments with the treatment itself. In fact, last year, Phase 3 data didn’t show results that would justify the company moving forward with a New Drug Application with the FDA.
Since then, it’s been a story about “strategic alternatives,” and Acasti brought on Oppenheimer & Co to help. The aim is to identify potential “mergers, acquisitions, or other initiatives” that involve the company and/or its current pipeline, including CaPre.
Read More
- Making A List Of Penny Stocks To Buy This Week? Analysts Like These 5
- Best Penny Stocks To Buy Next Week? 5 Biotechs You Might've Missed
Last month, Acasti secured $28.5 million in funding at $0.3445 per share. This capital is expected to offer additional flexibility in its ongoing review of strategic alternatives. Aside from this, not much more has been said so far. Regardless, though, ACST stock continues pushing higher this month.
#5. Luokung Technology Corp.
In light of these developments and fresh money in hand, will this be one of the cheap penny stocks on your watch list in February?
Penny Stocks Under $1 Include Higher Risk
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
